Weight-adjusted Waist Index (WWI) is a novel tool for evaluating human metabolism. By standardizing waist circumference with body weight, it compensates for the limitations of traditional Body Mass Index (BMI). It performs remarkably well in predicting health risks, including type 2 diabetes mellitus (T2DM), cardiovascular diseases, and metabolic syndrome. This paper summarizes the research progress of WWI in T2DM and its complications. It is found that WWI can effectively predict the onset of diabetes and various complications, with superior assessment efficacy compared with conventional indicators, and combined indexes possess higher predictive value. At present, WWI has not been widely applied clinically, and its diagnostic criteria and action mechanism remain to be further explored. After relevant research is improved, WWI is expected to serve as an effective assessment method for diabetes risk screening and complication early warning.
Chinese Medical Association Diabetes Society, 2025, Chinese Guidelines for the Prevention and Treatment of Diabetes (2024 Edition). Chinese Journal of Diabetes, 17(01): 136–139.
Lingvay I, Sumithran P, Cohen R, et al., 2022, Obesity Management as a Primary Treatment Goal for Type 2 Diabetes: Time to Reframe the Conversation. Lancet, 399(10322): 394–405.
Park Y, Kim N, Kwon T, et al., 2018, A Novel Adiposity Index as an Integrated Predictor of Cardiometabolic Disease Morbidity and Mortality. Scientific Reports, 8(1): 16753.
Zheng D, Zhao S, Luo D, et al., 2023, Association Between the Weight-Adjusted Waist Index and the Odds of Type 2 Diabetes Mellitus in United States Adults: A Cross-Sectional Study. Frontiers in Endocrinology (Lausanne), 14: 1325454.
Piché M, Tchernof A, Després P, 2020, Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circulation Research, 126(11): 1477–1500.
Liu Y, Sun S, Zou Q, et al., 2024, Correlation Between Weight-Adjusted Waist Index and Coronary Heart Disease: NHANES 1999–2020. Frontiers in Cardiovascular Medicine, 11: 1445802.
Zhang Y, Zhang M, Wang X, et al., 2024, Relationship Between Weight-Adjusted-Waist Index and All-Cause and Cardiovascular Mortality in Individuals with Type 2 Diabetes. Diabetes, Obesity and Metabolism, 26(12): 5621–5629.
Watanabe K, Sato E, Mishima E, et al., 2022, What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances. International Journal of Molecular Sciences, 24(1): 570.
Ding Y, Lv S, Xie R, et al., 2024, Association of Weight-Adjusted Waist Index and Diabetic Kidney Disease in Type 2 Diabetes Mellitus. Endocrine Connections, 13(4): e230491.
O’Brien P, Hinder L, Callaghan B, et al., 2017, Neurological Consequences of Obesity. Lancet Neurology, 16(6): 465–477.